← All Investors
EUPRAXIA PHARMACEUTICALS INC
EPRX
Holders
2
Combined Value
$8M
Combined Shares
1,197,751
Current Price
$6.29
52W High
$9.32
vs 52W High
−32.5%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Steve Cohen - Point72 | $7M | 0.01% | ~$7.47 | −15.8% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $1M | 0.00% | ~$7.24 | −13.1% | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Steve Cohen - Point72 | BUY | +$1M | ~$7.24 |
| Q1 2026 | Ken Griffin - Citadel Advisors | NEW BUY | +$1M | ~$7.24 |
| Q4 2025 | Steve Cohen - Point72 | NEW BUY | +$5M | ~$7.55 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$107K | ~$5.92 |
| Q2 2025 | Ken Griffin - Citadel Advisors | BUY | +$36K | ~$5.92 |
| Q1 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$39K | ~$3.27 |
| Q1 2025 | Israel Englander - Millennium Management | SOLD OUT | −$31K | ~$3.13 |
| Q4 2024 | Israel Englander - Millennium Management | NEW BUY | +$31K | ~$3.13 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 1,197,751 | +68.2% | $8M | $7.24 |
| Q4 2025 | 1 | 712,104 | +3804.9% | $5M | $7.55 |
| Q2 2025 | 1 | 18,236 | +51.3% | $107K | $5.92 |
| Q1 2025 | 1 | 12,054 | +20.5% | $39K | $3.27 |
| Q4 2024 | 1 | 10,000 | — | $31K | $3.13 |